Fusion Pharmaceuticals Probability of Future Stock Price Finishing Under 3.75
Fusion Pharmaceuticals' future price is the expected price of Fusion Pharmaceuticals instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Fusion Pharmaceuticals performance during a given time horizon utilizing its historical volatility. Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
Please specify Fusion Pharmaceuticals' target price for which you would like Fusion Pharmaceuticals odds to be computed.
Fusion |
Fusion Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Fusion Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Fusion Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Fusion Pharmaceuticals is not yet fully synchronised with the market data | |
| Fusion Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Fusion Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 2.07 M. Net Loss for the year was (94.9 M) with loss before overhead, payroll, taxes, and interest of (57.43 M). | |
| Fusion Pharmaceuticals currently holds about 198.42 M in cash with (81.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.57. | |
| Over 87.0% of the company shares are owned by institutional investors |
Fusion Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Fusion Stock often depends not only on the future outlook of the current and potential Fusion Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Fusion Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 65.6 M | |
| Cash And Short Term Investments | 234.1 M |
Fusion Pharmaceuticals Technical Analysis
Fusion Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Fusion Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Fusion Pharmaceuticals. In general, you should focus on analyzing Fusion Stock price patterns and their correlations with different microeconomic environments and drivers.
Fusion Pharmaceuticals Predictive Forecast Models
Fusion Pharmaceuticals' time-series forecasting models is one of many Fusion Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Fusion Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Fusion Pharmaceuticals
Checking the ongoing alerts about Fusion Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Fusion Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Fusion Pharmaceuticals is not yet fully synchronised with the market data | |
| Fusion Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Fusion Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 2.07 M. Net Loss for the year was (94.9 M) with loss before overhead, payroll, taxes, and interest of (57.43 M). | |
| Fusion Pharmaceuticals currently holds about 198.42 M in cash with (81.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.57. | |
| Over 87.0% of the company shares are owned by institutional investors |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Consideration for investing in Fusion Stock
If you are still planning to invest in Fusion Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Fusion Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |